Precigen Inc PGEN.OQ PGEN.O is expected to show a rise in quarterly revenue when it reports results on March 19 for the period ending December 31 2024
The Germantown Maryland-based company is expected to report a 9.9% increase in revenue to $1.35 million from $1.23 million a year ago, according to the mean estimate from 4 analysts, based on LSEG data.
LSEG's mean analyst estimate for Precigen Inc is for a loss of 6 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and 1 "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Precigen Inc is $6.00, above its last closing price of $1.80.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Sep. 30 2024
-0.08
-0.08
-0.09
Missed
-12.5
Jun. 30 2024
-0.10
-0.10
-0.10
Met
-3.7
Mar. 31 2024
-0.09
-0.09
-0.10
Missed
-14.2
Dec. 31 2023
-0.08
-0.13
Missed
-67.7
Sep. 30 2023
-0.08
-0.08
-0.08
Met
-2.6
Jun. 30 2023
-0.10
-0.10
-0.08
Beat
20
Mar. 31 2023
-0.10
-0.09
-0.10
Missed
-9.6
Dec. 31 2022
-0.10
-0.10
-0.11
Missed
-10
This summary was machine generated March 17 at 20:12 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)